| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.9× | −1.8× | |
| Price / Book | 8.9× | 2.1× | |
| Price / Sales | 12.9× | 4.0× | |
| Price / Free cash flow | −1.5× | −1.6× | |
| EV / EBITDA | −1.8× | −1.1× | |
| Earnings yield | −52.7% | −14.0% | |
| Free cash flow yield | −67.8% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,282.22 | −1.87% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.38 | −1.58% | $634.04B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.26 | +0.02% | $504.09B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.93 | −0.25% | $380.52B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.00 | −1.52% | $357.74B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.98 | −3.39% | $272.06B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.25 | −0.76% | $265.59B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $667.91 | −1.28% | $246.96B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.59 | −1.05% | $239.28B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.05 | −0.09% | $194.73B | 22.9× | 37.5% | +26.7% |
